New study aims to sharpen vision tests for retinal disease patients
NCT ID NCT07502664
First seen Apr 24, 2026 · Last updated Jun 23, 2026 · Updated 15 times
Summary
This study is developing and testing new ways to measure vision and navigation skills in people with severe inherited retinal diseases like retinitis pigmentosa and Stargardt disease. Researchers will enroll 25 participants to see which tests are most reliable and practical. The goal is to create better endpoints for future clinical trials, not to test a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vision Research and Assessment Institute
RECRUITINGIrvine, California, 92614, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better, more reliable tests for measuring vision in future clinical trials for retinal diseases.
What could go wrong
This is a small, early-stage observational study focused on measurement methods, not a treatment. It may not directly benefit participants or lead to a therapy.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.